Pain, Agitation/Sedation, Delirium, Immobility, Sleep Disruption, and Neuromuscular Blockade
interruption, nurses stopped benzodiazepine and opiate infusions once a day and assessed hourly for
wakefulness (e.g., a light SAS or RASS score, plus ability to follow at least three commands).
Clinical outcomes (published 2012): There was no difference in the primary outcome of time to
successful extubation between the two groups (7 days in both groups). There was a significant
difference in time to extubation in the prespecified surgical/trauma group between sedation
protocol with daily sedation interruption and sedation protocol alone (6 vs. 13 days; hazard ratio
[HR] 2.55; 95% CI, 1.40β5.44). No difference in time to extubation was detected between groups
among medical ICU patients (9 vs. 8 days; HR 0.92; 95% CI, 0.72β1.18). However, significantly
lower daily doses of both benzodiazepines and opiates boluses and continuous infusions were
used in the sedation protocolβalone group than in the sedation protocol plus interruption group.
Although the sedation protocol suggested to target light sedation, the actual mean RASS/SAS was
not reported for either group making it unclear how deeply sedated either group was.
(ICDSC) was diagnosed in 53.8% of patients in the study; there was no difference in delirium
in the sedation protocolβalone group versus the protocol plus daily sedation interruption group.
Patients who had delirium had a longer duration of mechanical ventilation, longer ICU and hospital
stay, longer use of restraints, higher rates of tracheostomy, and higher incidence of unintentional
device removal. Patients with delirium received almost the twice the mean dose of midazolam
equivalents/patient/day (104 mg vs. 57 mg), higher fentanyl equivalents/patient/day (1497 mcg vs.
1150 mcg), more frequent use of anticholinergics (18 vs. 8.6%), and more frequent use of trazadone
or zopiclone (17.7 vs. 9.8%) than did patients who were not delirious. Patients who developed
delirium had a higher incidence of alcohol and cigarette use than did patients who did not develop
delirium.
Recall in ICU survivors (published 2015): The SLEAP investigator study did patient interviews on
days 3, 28, and 90 post-ICU discharge to determine differences in recall between the sedation-alone
protocol group and the protocol plus daily sedation interruption group. There were no differences in
type of recall between the sedation strategies. Delusional memories were common at day 28 (70%
of patients) but were unrelated to the presence of delirium or the total dose of benzodiazepines or
opiates. Patients with no recall had received lower total doses of benzodiazepines than had patients
with recall. Emotional memories such as panic and confusion declined over time.
Score
Term
Description
+4
Combative
Overtly combative or violent; immediate danger to staff
+3
Very agitated
Pulls on or removes tube(s) or has aggressive behavior toward staff
+2
Agitated
Frequently nonpurposeful movement or patient-ventilator dyssynchrony
+1
Restless
Anxious or apprehensive, but movements not aggressive or vigorous
Alert and calm
β1
Drowsy
Not fully alert but has sustained (> 10 s) awakening, with eye contact, to voice
β2
Light sedation
Briefly (< 10 s) awakens with eye contact to voice
β3
Moderate sedation
Any movement (but no eye contact) to voice
β4
Deep sedation
No response to voice, but any movement to physical stimulation
β5
Unarousable
No response to voice or physical stimulation